Back to GetFilings.com



 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM 10-Q

 

(Mark One)

 

 

 

ý

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

 

 

 

 

For the quarterly period ended July 31, 2003

 

 

 

o

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

 

 

Commission file number 1-8978

 

LONGS DRUG STORES CORPORATION

(Exact name of registrant as specified in its charter)

 

Maryland

 

68-0048627

(State or other jurisdiction of
incorporation or organization)

 

(I.R.S. Employer
Identification No.)

 

 

 

141 North Civic Drive
Walnut Creek, California

 

94596

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code:  (925) 937-1170

 

Indicate by check mark whether the registrant:  (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes  ý

 

No  o

 

Indicate by check mark whether the registrant is an accelerated filer (defined in Rule 12b-2 of the Exchange Act).

 

Yes  ý

 

No  o

 

There were 37,457,625 shares of common stock outstanding as of August 28, 2003.

 

 



 

Table of Contents

 

PART I – FINANCIAL INFORMATION

 

 

 

Item 1

 

Condensed Consolidated Financial Statements

Item 2

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Item 3

 

Quantitative and Qualitative Disclosures of Market Risk

Item 4

 

Controls and Procedures

 

 

 

PART II – OTHER INFORMATION

 

 

 

Item 4

 

Submission of Matters to a Vote of Security Holders

Item 6

 

Exhibits and Reports on Form 8-K

Signature Page

 



 

PART I – FINANCIAL INFORMATION

 

Item 1.                       Condensed Consolidated Financial Statements

 

Condensed Consolidated Statements of Income (unaudited)

 

 

 

For the 13 weeks ended

 

For the 26 weeks ended

 

 

 

July 31,
2003

 

August 1,
2002

 

July 31,
2003

 

August 1,
2002

 

 

 

(Thousands Except Per Share Amounts)

 

 

 

 

 

 

 

 

 

 

 

Sales

 

$

1,109,463

 

$

1,101,630

 

$

2,212,593

 

$

2,191,459

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of sales

 

821,424

 

817,368

 

1,639,447

 

1,631,170

 

Gross profit

 

288,039

 

284,262

 

573,146

 

560,289

 

 

 

 

 

 

 

 

 

 

 

Operating and administrative expenses

 

251,602

 

243,808

 

502,122

 

480,419

 

Depreciation and amortization

 

21,891

 

19,216

 

43,687

 

38,082

 

Provision for store closures and asset impairment

 

2,543

 

 

2,543

 

 

Legal settlements and other disputes

 

 

469

 

 

469

 

Operating income

 

12,003

 

20,769

 

24,794

 

41,319

 

Interest expense

 

3,697

 

3,397

 

7,256

 

6,728

 

Interest income

 

(124

)

(276

)

(239

)

(646

)

Income before income taxes and cumulative effect of accounting change

 

8,430

 

17,648

 

17,777

 

35,237

 

Income taxes

 

3,170

 

6,707

 

6,684

 

13,326

 

Income before cumulative effect of accounting change

 

5,260

 

10,941

 

11,093

 

21,911

 

 

 

 

 

 

 

 

 

 

 

Cumulative effect of accounting change (net of tax benefit of $16,410)

 

 

 

 

(24,625

)

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

5,260

 

$

10,941

 

$

11,093

 

$

(2,714

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic earnings (loss) per common share:

 

 

 

 

 

 

 

 

 

Income before cumulative effect of accounting change

 

$

0.14

 

$

0.29

 

$

0.30

 

$

0.58

 

Cumulative effect of accounting change (net of tax benefit of $0.43)

 

 

 

 

(0.65

)

Net income (loss)

 

$

0.14

 

$

0.29

 

$

0.30

 

$

(0.07

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings (loss) per common share:

 

 

 

 

 

 

 

 

 

Income before cumulative effect of accounting change

 

$

0.14

 

$

0.29

 

$

0.30

 

$

0.57

 

Cumulative effect of accounting change (net of tax benefit of $0.43)

 

 

 

 

(0.64

)

Net income (loss)

 

$

0.14

 

$

0.29

 

$

0.30

 

$

(0.07

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dividends per common share

 

$

0.14

 

$

0.14

 

$

0.28

 

$

0.28

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of shares outstanding:

 

 

 

 

 

 

 

 

 

Basic

 

37,038

 

37,907